FDA Approves Abbott's Novel Dissolvable Stent Therapy for Peripheral Artery Disease
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
American College of Cardiology
OCTOBER 28, 2024
The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.
Becker's Hospital Review - Cardiology
NOVEMBER 7, 2024
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
American College of Cardiology
OCTOBER 29, 2024
The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.
Journal of Cardiothoracic Surgery
DECEMBER 18, 2024
This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.
American College of Cardiology
SEPTEMBER 2, 2024
A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)
JAMA Cardiology
DECEMBER 22, 2024
This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.
American College of Cardiology
SEPTEMBER 2, 2024
The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.
DAIC
MARCH 1, 2024
Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006). vs. 28.7%; P=0.006).
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc., There was no restriction on time from last known well (TLKW) to MT.
DAIC
NOVEMBER 8, 2024
In the DA+DCB arm, there was a trend toward higher stent-free patency through 12 months (79.1% versus 68.1%, · P=0.09) and a significantly lower provisional stenting rate (9.5% among 6 randomized controlled trials (RCTs) (172 patients), comparing favorably to published meta-analysis rates for uncoated balloon angioplasty (47.4%
Stroke Journal
FEBRUARY 1, 2024
Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. The stent-retriever was re-sheathed into the microcatheter before retrieval. Further prospective data is warranted.
Stroke Journal
JANUARY 30, 2025
The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.
Medical Xpress - Cardiology
NOVEMBER 4, 2024
27 to 30 in Washington, D.C.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).
Medical Xpress - Cardiology
SEPTEMBER 2, 2024
Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
Journal of Cardiovascular Electrophysiology
NOVEMBER 20, 2024
Balloon angioplasty seems to be the widely preferred treatment of choice. The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. The stenosis was treated with a stent.
Stroke Journal
MARCH 23, 2025
The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.
Know Your Heart
FEBRUARY 20, 2019
Coronary Artery Stents What are coronary artery stents? A stent is a tiny device made of surgical stainless steel that is placed inside an artery to hold it open and allow blood to flow through the blood vessel. When are coronary stents used? Coronary stents are used as a routine part of most angioplasty procedures.
DAIC
APRIL 11, 2024
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.
Med Page Today
APRIL 30, 2024
(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.
Stroke Journal
FEBRUARY 1, 2024
Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.
Stroke Journal
JANUARY 30, 2025
Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
The American Journal of Cardiology
JULY 18, 2024
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies
Stroke Journal
FEBRUARY 1, 2024
In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment. 10.43, p=0.0325).Conclusions:The 10.43, p=0.0325).Conclusions:The
American College of Cardiology
MARCH 20, 2024
The goal of the AGENT IDE trial was to assess the safety and efficacy of a paclitaxel-coated balloon (drug-coated balloon; DCB) to conventional balloon angioplasty among patients with coronary in-stent restenosis (ISR).
American College of Cardiology
OCTOBER 29, 2024
The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. 4 Recent literature has reported clinical benefits associated with rescue stenting in the setting of ICAD‐related MT‐refractory strokes.5
Circulation: Cardiovascular Interventions
APRIL 25, 2025
Options for endovascular interventions include balloon angioplasty (percutaneous transluminal angioplasty [standard], drug-coated balloon), stenting (bare metal, drug-eluting, covered stents), with or without adjunct therapy (atherectomy or intravascular lithotripsy).
Stroke Journal
JANUARY 30, 2025
All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.
Med Page Today
SEPTEMBER 2, 2024
(MedPage Today) -- LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed. DCB with rescue use of.
American College of Cardiology
MARCH 20, 2024
He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent.
Frontiers in Cardiovascular Medicine
DECEMBER 3, 2024
A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.MethodsAll patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. At a mean follow-up imaging duration of 28.7 ± 23.6 months
CardiacWire
MARCH 2, 2024
The United States has been way behind other nations in using drug-coated balloons (DCB) to treat coronary in-stent restenosis (ISR), but that’s about to change thanks to the FDA approval of Boston Scientific’s AGENT Drug-Coated Balloon. vs 12.3%) Stent thrombosis (0.0% vs 12.3%) Stent thrombosis (0.0%
HeartRhythm
MARCH 31, 2025
Management often involves removal of the TVL, angioplasty of the vein and stenting in certain situations. Superior vena cava syndrome (SVC) is an uncommon complication of transvenous leads (TVL).
DAIC
APRIL 12, 2024
If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Hence, in the US, many CTO patients are instead sent for bypass surgery.
Stroke Journal
FEBRUARY 1, 2024
Introduction:For a subset of patients with acute ischemic stroke (AIS) with large vessel occlusion (LVO) mechanical thrombectomy with a stent retriever and/or aspiration is insufficient to revascularize the target artery. Rescue therapy with angioplasty alone or with stenting has been utilized.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Rescue strategies options, including balloon angioplasty alone, rescue stenting (RS) alone, or stent with balloon angioplasty, have shown promise in observational studies and meta‐analyses [3, 4].
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
The combined and matched subgroups were pulmonary artery stenting (Stent PUL ), aorta angioplasty (Plasty AO ), pulmonary artery angioplasty (Plasty PUL ), or a combination of the latter two (Plasty). The decrease of AK BW and DAP BW in the Stent PUL and Plasty PUL subgroups was not statistically significant.
Coronary Artery Disease Journal
JANUARY 11, 2024
No abstract available
Stroke Journal
FEBRUARY 1, 2024
Introduction:Current evidence suggests that acute carotid artery stenting (CAS) for cervical lesions is associated with better functional outcomes in patients with acute stroke with tandem lesions (TLs) treated with endovascular treatment (EVT).
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Endovascular intervention was defined as either angioplasty, stenting, or a combination of both. ConclusionWhile limited by small subgroup sample size, medical management only was associated with relatively high rates of reocclusion, while proactive angioplasty/stenting with performed best.
HeartRhythm
JULY 2, 2024
The management of this problem might require a multidisciplinary approach, often involving TV lead extraction (TLE) followed by angioplasty and stenting. Data on Transvenous (TV) lead-associated superior vena cava (SVC) syndrome are limited.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content